PortfoliosLab logoPortfoliosLab logo
MREO vs. ISRG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MREO vs. ISRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mereo BioPharma Group plc (MREO) and Intuitive Surgical, Inc. (ISRG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MREO achieves a -19.80% return, which is significantly higher than ISRG's -28.09% return.


MREO

1D
-1.53%
1M
16.41%
YTD
-19.80%
6M
-82.95%
1Y
-87.39%
3Y*
-31.94%
5Y*
-37.84%
10Y*

ISRG

1D
1.24%
1M
-9.96%
YTD
-28.09%
6M
-28.51%
1Y
-26.20%
3Y*
9.27%
5Y*
8.00%
10Y*
19.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MREO vs. ISRG - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
MREO
Mereo BioPharma Group plc
-19.80%-88.09%51.52%208.00%-53.12%-55.31%9.15%-49.54%
ISRG
Intuitive Surgical, Inc.
-28.09%8.51%54.72%27.14%-26.15%31.76%38.39%16.34%

Correlation

The correlation between MREO and ISRG is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Apr 25, 2019

0.19

Fundamentals

Market Cap

MREO:

$53.59M

ISRG:

$146.54B

EPS

MREO:

-$0.22

ISRG:

$8.24

PS Ratio

MREO:

106.89

ISRG:

13.91

PB Ratio

MREO:

1.57

ISRG:

8.33

Total Revenue (TTM)

MREO:

$500.00K

ISRG:

$10.58B

Gross Profit (TTM)

MREO:

$366.00K

ISRG:

$7.02B

EBITDA (TTM)

MREO:

-$39.61M

ISRG:

$3.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MREO vs. ISRG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MREO
MREO Risk / Return Rank: 1414
Overall Rank
MREO Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
MREO Sortino Ratio Rank: 2424
Sortino Ratio Rank
MREO Omega Ratio Rank: 2020
Omega Ratio Rank
MREO Calmar Ratio Rank: 44
Calmar Ratio Rank
MREO Martin Ratio Rank: 88
Martin Ratio Rank

ISRG
ISRG Risk / Return Rank: 88
Overall Rank
ISRG Sharpe Ratio Rank: 77
Sharpe Ratio Rank
ISRG Sortino Ratio Rank: 88
Sortino Ratio Rank
ISRG Omega Ratio Rank: 1010
Omega Ratio Rank
ISRG Calmar Ratio Rank: 99
Calmar Ratio Rank
ISRG Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MREO vs. ISRG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mereo BioPharma Group plc (MREO) and Intuitive Surgical, Inc. (ISRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MREOISRGDifference

Sharpe ratio

Return per unit of total volatility

-0.65

-0.85

+0.20

Sortino ratio

Return per unit of downside risk

-0.30

-1.23

+0.93

Omega ratio

Gain probability vs. loss probability

0.94

0.86

+0.08

Calmar ratio

Return relative to maximum drawdown

-0.95

-0.82

-0.13

Martin ratio

Return relative to average drawdown

-1.39

-1.65

+0.26

MREO vs. ISRG - Sharpe Ratio Comparison

The current MREO Sharpe Ratio is -0.65, which is comparable to the ISRG Sharpe Ratio of -0.85. The chart below compares the historical Sharpe Ratios of MREO and ISRG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MREOISRGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.65

-0.85

+0.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.38

0.24

-0.62

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.59

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.30

0.47

-0.77

Drawdowns

MREO vs. ISRG - Drawdown Comparison

The maximum MREO drawdown since its inception was -96.35%, which is greater than ISRG's maximum drawdown of -82.26%. Use the drawdown chart below to compare losses from any high point for MREO and ISRG.


Loading charts...

Drawdown Indicators


MREOISRGDifference

Max Drawdown

Largest peak-to-trough decline

-96.35%

-82.26%

-14.09%

Max Drawdown (1Y)

Largest decline over 1 year

-91.93%

-32.14%

-59.79%

Max Drawdown (3Y)

Largest decline over 3 years

-95.13%

-34.10%

-61.03%

Max Drawdown (5Y)

Largest decline over 5 years

-95.13%

-49.90%

-45.23%

Max Drawdown (10Y)

Largest decline over 10 years

-49.90%

Current Drawdown

Current decline from peak

-94.86%

-33.28%

-61.58%

Average Drawdown

Average peak-to-trough decline

-65.90%

-21.27%

-44.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

62.66%

15.91%

+46.75%

Volatility

MREO vs. ISRG - Volatility Comparison

Mereo BioPharma Group plc (MREO) has a higher volatility of 36.10% compared to Intuitive Surgical, Inc. (ISRG) at 11.07%. This indicates that MREO's price experiences larger fluctuations and is considered to be riskier than ISRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MREOISRGDifference

Volatility (1M)

Calculated over the trailing 1-month period

36.10%

11.07%

+25.03%

Volatility (6M)

Calculated over the trailing 6-month period

224.43%

20.23%

+204.20%

Volatility (1Y)

Calculated over the trailing 1-year period

134.18%

30.83%

+103.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

100.56%

33.15%

+67.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

113.66%

32.38%

+81.28%

Dividends

MREO vs. ISRG - Dividend Comparison

Neither MREO nor ISRG has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

MREO vs. ISRG - Financials Comparison

This section allows you to compare key financial metrics between Mereo BioPharma Group plc and Intuitive Surgical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00B202220232024202520260
2.77B
(MREO) Total Revenue
(ISRG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MREO and ISRG have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MREO has higher volatility (36.10%) compared to ISRG (11.07%). In terms of maximum drawdown, MREO dropped -96.35% vs ISRG's -82.26%.

MREO currently has the higher Sharpe Ratio (-0.65 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MREO and ISRG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer